GIC Sub-Industry »Biotechnology« (200+)
Filter by Size, Price, EPS, Revenue, Debt, Returns and many other Dividend and Fundamental Data.
Results
200 matches| SYMBOL | INDUSTRY | MKT CAP | VRT | SIGNAL | SAFETY | RS | DIV. YIELD |
|---|---|---|---|---|---|---|---|
|
ABBV AbbVie |
Biotechnology
Medicines, Therapies, Injectables |
369B | 44 | 0.45 | 46 | 42 | 4.2% |
|
AMGN Amgen |
Biotechnology
Biologics, Treatments, Therapies |
188B | 65 | 0.70 | 57 | 61 | 3.1% |
|
GILD Gilead Sciences |
Biotechnology
Antivirals, Oncology, Rare Diseases |
173B | 69 | 0.28 | 83 | 70 | 2.7% |
|
NOV Novo Nordisk |
Biotechnology
Diabetes, Obesity, Rare Disease |
168B | 48 | -0.56 | 82 | 4 | 4.6% |
|
VRTX Vertex |
Biotechnology
Medicines, Therapies, Treatments |
113B | 58 | 0.06 | 92 | 25 | - |
|
REGN Regeneron |
Biotechnology
Eye Disease, Asthma, Cancer |
79.7B | 66 | 0.30 | 92 | 70 | 0.5% |
|
ARGX argenx |
Biotechnology
Biologics, Treatments, Autoimmune |
50.0B | 65 | 0.51 | 72 | 65 | - |
|
ALNY Alnylam |
Biotechnology
RNAi Therapeutics, Onpattro |
44.5B | 53 | -0.81 | 31 | 24 | - |
|
HLN Haleon |
Biotechnology
Oral Care, Vitamins, Pain Relief |
43.9B | 56 | -0.37 | 89 | 28 | 3.0% |
|
ONC BeiGene |
Biotechnology
Cancer Therapies, Immunotherapy |
35.6B | 47 | -0.05 | 41 | 48 | - |
|
INSM Insmed |
Biotechnology
Rare Disease Therapies, Lung |
31.7B | 29 | -0.40 | 25 | 69 | - |
|
RVMD Revolution Medicines |
Biotechnology
Cancer Therapies, Drug |
30.2B | 42 | 0.35 | 78 | 99 | - |
|
NTRA Natera |
Biotechnology
Prenatal Screening, Cancer |
29.4B | 47 | -0.11 | 34 | 46 | - |
|
BIIB Biogen |
Biotechnology
Neurology Drugs, Biosimilars, Rare |
26.5B | 62 | -0.08 | 86 | 74 | - |
|
UTHR United Therapeutics |
Biotechnology
Treating Pulmonary Arterial |
25.3B | 72 | 0.71 | 82 | 89 | - |
|
BNTX BioNTech SE |
Biotechnology
Cancer, Vaccines, Immunotherapy |
24.2B | 30 | -0.07 | 81 | 23 | - |
|
ROIV Roivant Sciences |
Biotechnology
Medicines, Therapies, Antibodies |
21.0B | 49 | 0.54 | 81 | 96 | - |
|
MRNA Moderna |
Biotechnology
Vaccines, Oncology, Rare |
20.1B | 40 | 0.58 | 32 | 93 | - |
|
INCY Incyte |
Biotechnology
Cancer Therapies, Dermatology |
19.1B | 76 | 0.28 | 85 | 65 | - |
|
GMAB Genmab AS |
Biotechnology
Antibody Therapies, Cancer Drugs |
17.4B | 61 | -0.36 | 82 | 44 | - |
|
SMMT Summit Therapeutics |
Biotechnology
Oncology Drug, Immunotherapy |
16.4B | 17 | 0.21 | 76 | 65 | - |
|
ASND Ascendis Pharma AS |
Biotechnology
Endocrinology, Therapies, Rare |
15.3B | 48 | -0.16 | 35 | 77 | - |
|
BBIO BridgeBio Pharma |
Biotechnology
Genetic Medicines, Small |
14.5B | 35 | 0.28 | 29 | 86 | - |
|
ERF Eurofins Scientific |
Biotechnology
Testing, Laboratory, Analysis |
14.3B | 64 | 0.36 | 81 | 51 | 1.1% |
|
NBIX Neurocrine |
Biotechnology
Neurological Drugs, Endocrine |
12.9B | 61 | 0.22 | 87 | 34 | - |
|
BIM Biomerieux |
Biotechnology
Diagnostic Tests, Culture Media |
12.8B | 53 | -0.50 | 90 | 11 | 0.7% |
|
IONS Ionis |
Biotechnology
RNA Medicines, Genetic Diseases |
12.4B | 43 | 0.11 | 59 | 87 | - |
|
MDGL Madrigal |
Biotechnology
Liver Drug, MASH Treatment |
11.9B | 32 | -0.16 | 26 | 78 | - |
|
EXEL Exelixis |
Biotechnology
Cancer Drugs, Targeted Therapies |
11.9B | 62 | 0.50 | 90 | 44 | - |
|
BMRN Biomarin |
Biotechnology
Rare Disease Therapies, Enzyme |
10.6B | 45 | -0.45 | 89 | 25 | - |
|
ABVX Abivax American |
Biotechnology
Obefazimod |
10.3B | 43 | -0.42 | 81 | 99 | - |
|
ABVX Abivax |
Biotechnology
Obefazimod, UlcerativeColitis |
10.1B | 40 | -0.53 | 81 | 99 | - |
|
ARWR Arrowhead |
Biotechnology
RNAi, Hepatic, Metabolic |
9.94B | 66 | -0.33 | 30 | 99 | - |
|
PCVX Vaxcyte |
Biotechnology
Vaccines, Pneumococcal, Bacterial |
8.97B | 42 | 0.77 | 75 | 90 | - |
|
PRAX Praxis Precision |
Biotechnology
Ulixacaltamide, Vormatrigine |
8.80B | 44 | -0.36 | 66 | 99 | - |
|
QIA QIAGEN |
Biotechnology
Diagnostics, Research Tools, Lab |
8.74B | 45 | -0.54 | 88 | 15 | 5.3% |
|
NUVL Nuvalent |
Biotechnology
Cancer Therapies, Drug Candidates |
8.08B | 33 | 0.35 | 71 | 63 | - |
|
IBRX Immunitybio |
Biotechnology
Anktiva, Cytokine Fusion Proteins |
8.03B | 49 | -0.71 | 26 | 97 | - |
|
CYTK Cytokinetics |
Biotechnology
Muscle Activators, Muscle |
8.01B | 33 | -0.20 | 30 | 79 | - |
|
HALO Halozyme |
Biotechnology
Enzymes, Drug Delivery, Biologics |
7.94B | 54 | -0.02 | 77 | 37 | - |
|
KRYS Krystal Biotech |
Biotechnology
Genetic Medicines, Skin |
7.62B | 60 | 0.15 | 87 | 80 | - |
|
KYMR Kymera Therapeutics |
Biotechnology
Drug Discovery, Protein |
7.34B | 43 | -0.35 | 81 | 95 | - |
|
BLTE Belite Bio |
Biotechnology
Eye Disease, Liver Disease |
6.90B | 39 | -0.43 | 76 | 94 | - |
|
ACLX Arcellx |
Biotechnology
Cancer Therapies, Immunotherapies |
6.72B | 41 | 0.85 | 72 | 92 | - |
|
PTGX Protagonist |
Biotechnology
Oral Peptides, Injectable |
6.68B | 46 | 0.59 | 36 | 91 | - |
|
APGE Apogee |
Biotechnology
Biologics, Antibodies, Treatments |
6.66B | 42 | 0.81 | 77 | 94 | - |
|
CNTA Centessa |
Biotechnology
Medicines, Treatments |
6.12B | 42 | 0.65 | 66 | 97 | - |
|
PTCT PTC Therapeutics |
Biotechnology
Rare Disease Drugs, Gene Therapy |
6.09B | 63 | 0.04 | 59 | 70 | - |
|
CELC Celcuity |
Biotechnology
Drug Candidates, Diagnostics |
5.97B | 59 | 0.85 | 81 | 99 | - |
|
COGT Cogent Biosciences |
Biotechnology
Cancer Drugs, Genetic Therapies |
5.90B | 48 | 0.11 | 74 | 99 | - |
|
RYTM Rhythm |
Biotechnology
Rare Diseases, Obesity |
5.76B | 27 | -0.54 | 39 | 26 | - |
|
MIRM Mirum |
Biotechnology
Rare Disease Treatments, Liver |
5.74B | 55 | 0.18 | 36 | 89 | - |
|
CGON CG Oncology, Common |
Biotechnology
Cancer Therapies, Bladder Cancer |
5.71B | 38 | 1.30 | 33 | 96 | - |
|
SRRK Scholar Rock Holding |
Biotechnology
Antibody, Inhibitor, Myostatin |
5.69B | 35 | 0.10 | 74 | 82 | - |
|
ERAS Erasca |
Biotechnology
Cancer Therapies, Drug |
5.66B | 45 | 0.54 | 72 | 99 | - |
|
ALKS Alkermes |
Biotechnology
Schizophrenia, Bipolar, Alcohol |
5.64B | 51 | 0.61 | 77 | 55 | - |
|
XENE Xenon |
Biotechnology
Neurological Therapeutics |
5.62B | 30 | 0.49 | 26 | 90 | - |
|
CRSP Crispr Therapeutics |
Biotechnology
Gene Editing, Cell Therapy, Drug |
5.46B | 28 | -0.82 | 80 | 45 | - |
|
SYRE Spyre Therapeutics |
Biotechnology
Antibodies, Inflammatory Disease |
5.44B | 45 | 0.49 | 72 | 99 | - |
|
TGTX TG Therapeutics |
Biotechnology
Antibodies, Cancer Treatments |
5.39B | 25 | -0.14 | 31 | 28 | - |
|
APLS Apellis |
Biotechnology
Eye Treatments, Blood Treatments |
5.21B | 55 | 0.59 | 31 | 96 | - |
|
DNTH Dianthus |
Biotechnology
Antibodies, Therapeutics |
5.21B | 38 | 0.39 | 41 | 99 | - |
|
IMVT Immunovant |
Biotechnology
Antibodies, Treatments, Diseases |
4.99B | 39 | 0.09 | 36 | 84 | - |
|
FOLD Amicus Therapeutics |
Biotechnology
Rare Disease Drugs, Gene Therapy |
4.54B | 53 | 0.70 | 31 | 92 | - |
|
LGND Ligand |
Biotechnology
Antiviral, Oncology, Nephrology |
4.26B | 61 | 0.48 | 82 | 87 | - |
|
NAMS NewAmsterdam Pharma |
Biotechnology
Cardiometabolic Therapies |
4.17B | 29 | -0.89 | 26 | 80 | - |
|
CRNX Crinetics |
Biotechnology
Paltusotine, Atumelnant, CRN09682 |
4.13B | 26 | -0.46 | 41 | 25 | - |
|
INDV Indivior Ordinary |
Biotechnology
Extended-Release Injection |
4.12B | 64 | 0.71 | 45 | 93 | - |
|
VKTX Viking Therapeutics |
Biotechnology
Metabolic Therapies, Endocrine |
3.97B | 24 | -0.57 | 81 | 59 | - |
|
GPCR Structure |
Biotechnology
Obesity Drugs, Fibrosis Drugs |
3.86B | 48 | -0.45 | 81 | 93 | - |
|
LEGN Legend Biotech |
Biotechnology
Cell Therapies, Oncology, Cancer |
3.80B | 15 | -1.02 | 36 | 7 | - |
|
DIA DiaSorin S.p.A. |
Biotechnology
Diagnostic Kits, Molecular |
3.75B | 36 | -0.40 | 76 | 8 | 1.3% |
|
ACAD ACADIA |
Biotechnology
Antipsychotic, Trofinetide |
3.71B | 32 | -0.33 | 29 | 30 | - |
|
EWTX Edgewise |
Biotechnology
Muscle Therapies, Cardiac |
3.52B | 45 | -0.24 | 81 | 95 | - |
|
KNSA Kiniksa |
Biotechnology
Cardiovascular Therapies, Skin |
3.51B | 58 | 0.36 | 49 | 86 | - |
|
DNLI Denali Therapeutics |
Biotechnology
Neuro Drugs, Enzyme Therapy |
3.44B | 38 | -0.95 | 79 | 79 | - |
|
VERA Vera Therapeutics |
Biotechnology
Biologics, Antibodies, Therapies |
3.23B | 43 | -0.75 | 81 | 84 | - |
|
ARQT Arcutis |
Biotechnology
Skin Treatments, Topical Creams |
3.11B | 39 | -0.21 | 29 | 77 | - |
|
DYN Dyne Therapeutics |
Biotechnology
Muscle Disease, Therapeutics |
3.08B | 47 | -0.38 | 74 | 92 | - |
|
CPRX Catalyst |
Biotechnology
Rare Disease Treatments, Seizure |
3.07B | 61 | 0.86 | 75 | 66 | - |
|
ORKA Oruka Therapeutics |
Biotechnology
Antibodies, Inflammation |
2.95B | 48 | 0.90 | 81 | 99 | - |
|
TWST Twist Bioscience |
Biotechnology
Synthetic DNA, Gene Synthesis |
2.94B | 31 | -0.13 | 42 | 88 | - |
|
ALMS Alumis |
Biotechnology
TYK2 Inhibitor, Autoimmune Drug |
2.93B | 43 | 0.64 | 26 | 99 | - |
|
IDYA Ideaya Biosciences |
Biotechnology
Oncology Therapeutics, Drug |
2.88B | 30 | 0.06 | 36 | 77 | - |
|
TNGX Tango Therapeutics |
Biotechnology
Oncology Drugs, Cancer Treatments |
2.85B | 47 | 0.12 | 69 | 99 | - |
|
TVTX Travere Therapeutics |
Biotechnology
Sparsentan, Tiopronin, Filspari |
2.83B | 55 | 0.82 | 26 | 95 | - |
|
RCUS Arcus Biosciences |
Biotechnology
Antibody, Inhibitor, Cancer |
2.81B | 47 | 0.18 | 59 | 95 | - |
|
BEAM Beam Therapeutics |
Biotechnology
Gene Editing, Therapeutics, RNA |
2.79B | 50 | -0.18 | 77 | 77 | - |
|
RLAY Relay Therapeutics |
Biotechnology
Oncology Drugs, Genetic Drugs |
2.73B | 56 | 0.90 | 81 | 99 | - |
|
SLNO Soleno Therapeutics |
Biotechnology
Rare diseases, Tablets |
2.72B | 39 | -0.01 | 67 | 19 | - |
|
VCYT Veracyte |
Biotechnology
Cancer Tests, Genomic Analysis |
2.70B | 38 | -0.25 | 42 | 25 | - |
|
KOD Kodiak Sciences |
Biotechnology
Retinal Therapeutics, Antibody |
2.67B | 47 | 0.11 | 66 | 99 | - |
|
IMNM Immunome |
Biotechnology
Cancer Therapies, Drug Candidates |
2.65B | 46 | 0.04 | 74 | 95 | - |
|
CLDX Celldex Therapeutics |
Biotechnology
Antibodies, Therapeutics |
2.56B | 29 | -0.26 | 31 | 86 | - |
|
ADMA ADMA Biologics |
Biotechnology
Biologics, Therapeutics, Plasma |
2.54B | 41 | -0.61 | 45 | 3 | - |
|
IRON Disc Medicine |
Biotechnology
Blood Disorders, Drug Development |
2.53B | 39 | -0.55 | 76 | 61 | - |
|
MLYS Mineralys |
Biotechnology
Medicines, Treatments, Aldosterone |
2.51B | 45 | 0.19 | 63 | 83 | - |
|
RARE Ultragenyx |
Biotechnology
Biologics, Gene Therapy, Enzyme |
2.42B | 20 | -0.99 | 41 | 17 | - |
|
BCRX BioCryst |
Biotechnology
Influenza Treatments, Rare Disease |
2.40B | 68 | 0.73 | 29 | 81 | - |
|
ZLAB Zai Lab |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
2.34B | 14 | -0.77 | 26 | 24 | - |
|
SRPT Sarepta Therapeutics |
Biotechnology
Exon-Skipping Injection, Gene |
2.28B | 20 | -1.00 | 31 | 16 | - |
|
DAWN Day One |
Biotechnology
Cancer Drugs, Clinical Trials |
2.22B | 40 | 0.48 | 29 | 99 | - |
|
SNDX Syndax |
Biotechnology
Cancer Therapies, Leukemia |
2.16B | 37 | -0.10 | 24 | 93 | - |
|
AUPH Aurinia |
Biotechnology
Autoimmune Therapies, Lupus |
2.14B | 71 | 0.67 | 31 | 86 | - |
|
STOK Stoke Therapeutics |
Biotechnology
Genetic Therapies, Antisense |
2.12B | 49 | -0.22 | 31 | 97 | - |
|
SION Sionna |
Biotechnology
Drug Development, Clinical Trials |
2.03B | 50 | 0.73 | 81 | 97 | - |
|
CAPR Capricor |
Biotechnology
Cell Therapies, Exosome Therapies |
2.01B | 43 | -0.03 | 66 | 99 | - |
|
ANAB AnaptysBio |
Biotechnology
Antibodies, Therapeutics |
1.98B | 68 | -0.03 | 36 | 97 | - |
|
GRAL GRAIL |
Biotechnology
Cancer Screening, Diagnostic Aids |
1.97B | 27 | -0.09 | 32 | 24 | - |
|
MESO Mesoblast |
Biotechnology
Cell Therapy, Inflammation, Heart |
1.96B | 16 | -0.39 | 33 | 58 | - |
|
ZYME Zymeworks Common |
Biotechnology
Antibody Therapeutics, Cancer |
1.96B | 34 | -0.11 | 41 | 92 | - |
|
GLPG Galapagos |
Biotechnology
Oncology Drugs, Immunology Drugs |
1.94B | 42 | -0.21 | 51 | 21 | - |
|
AGIO Agios Pharm |
Biotechnology
Medicines, Anemias, Thalassemia |
1.93B | 31 | 0.07 | 33 | 52 | - |
|
PHM Pharma Mar S.A. |
Biotechnology
Oncology Drugs, Cancer Treatments |
1.91B | 66 | 0.37 | 66 | 71 | 1.0% |
|
TYRA Tyra Biosciences |
Biotechnology
Biologics, Therapies, Oncology |
1.88B | 45 | -0.01 | 77 | 98 | - |
|
PVLA Palvella |
Biotechnology
Genetic Skin, Rare Diseases |
1.84B | 44 | -0.31 | 74 | 99 | - |
|
PHVS Pharvaris BV |
Biotechnology
Rare Disease Therapies, Angioedema |
1.82B | 41 | -0.20 | 81 | 83 | - |
|
NRIX Nurix Therapeutics |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
1.75B | 36 | -0.33 | 41 | 77 | - |
|
RXRX Recursion |
Biotechnology
Drug Discovery, Clinical Trials |
1.73B | 24 | -0.98 | 41 | 5 | - |
|
TSHA Taysha Gene |
Biotechnology
Gene Therapies, Nervous System |
1.72B | 54 | 0.38 | 77 | 97 | - |
|
VCEL Vericel Ord |
Biotechnology
Cellular Therapies, Skin |
1.72B | 41 | -0.61 | 77 | 18 | - |
|
NTLA Intellia |
Biotechnology
In Vivo, Ex Vivo, CRISPR, CAR-T |
1.68B | 38 | -0.71 | 34 | 70 | - |
|
NANO Nanobiotix S.A |
Biotechnology
Cancer Therapy, Nanoparticles |
1.61B | 36 | -0.47 | 31 | 99 | - |
|
NUVB Nuvation Bio |
Biotechnology
Cancer Drugs, Lung Cancer, Solid |
1.60B | 41 | 0.00 | 31 | 89 | - |
|
OCS Oculis Holding |
Biotechnology
Eye Treatments, Drug Candidates |
1.58B | 26 | -0.02 | 31 | 78 | - |
|
IMCR Immunocore Holdings |
Biotechnology
Cancer Drugs, Viral Cures |
1.57B | 20 | -0.72 | 74 | 24 | - |
|
IOVA Iovance |
Biotechnology
Cell Therapies, Cancer Treatments |
1.57B | 29 | -0.48 | 32 | 90 | - |
|
ARDX Ardelyx |
Biotechnology
IBS Therapy, Phosphate Reducer |
1.52B | 35 | -0.19 | 31 | 63 | - |
|
VIR Vir Biotechnology |
Biotechnology
Antibodies, Therapies, Vaccines |
1.49B | 45 | 0.76 | 31 | 94 | - |
|
IMTX Immatics |
Biotechnology
Cancer Therapies, Cell Therapy |
1.48B | 39 | 0.02 | 38 | 89 | - |
|
MBX MBX Biosciences |
Biotechnology
Peptide Therapies, Endocrine |
1.47B | 48 | -0.06 | 81 | 97 | - |
|
PGEN Precigen |
Biotechnology
Gene Therapies, Cell Therapies |
1.47B | 34 | -0.27 | 31 | 90 | - |
|
GLUE Monte Rosa |
Biotechnology
Drug Discovery, Cancer Treatments |
1.46B | 37 | 0.53 | 36 | 97 | - |
|
OLMA Olema |
Biotechnology
Cancer Therapies, Drug |
1.40B | 48 | -0.04 | 74 | 97 | - |
|
BCAX Bicara Therapeutics |
Biotechnology
Cancer Drugs, Antibodies, Therapies |
1.38B | 46 | 0.49 | 80 | 92 | - |
|
ATAI ATAI Life Sciences |
Biotechnology
Mental Health, Psychedelics |
1.38B | 29 | -0.23 | 24 | 86 | - |
|
BHVN Biohaven |
Biotechnology
Neurological Therapies, Oncology |
1.38B | 26 | -0.99 | 81 | 4 | - |
|
NVAX Novavax |
Biotechnology
Vaccines, Infectious Diseases |
1.37B | 44 | -0.63 | 33 | 62 | - |
|
DBV DBV Technologies |
Biotechnology
Peanut Patch, Milk Patch |
1.35B | 39 | -0.41 | 36 | 90 | - |
|
MLTX MoonLake |
Biotechnology
Inflammatory Therapies, Skin |
1.32B | 27 | -0.71 | 81 | 24 | - |
|
DBVT DBV Technologies |
Biotechnology
Allergy Treatments, Patches |
1.31B | 32 | -0.73 | 31 | 90 | - |
|
ZBIO Zenas BioPharma |
Biotechnology
Antibodies, Therapies, Immunology |
1.27B | 41 | -0.20 | 74 | 86 | - |
|
CRVS Corvus |
Biotechnology
Cancer Treatments, Immune |
1.27B | 43 | 0.72 | 66 | 99 | - |
|
PHARM Pharming |
Biotechnology
Rare Disease Therapies, Protein |
1.23B | 63 | -0.59 | 54 | 82 | - |
|
MPLT MapLight |
Biotechnology
CNS Treatments, Drug Candidates |
1.23B | 40 | 0.71 | 66 | 91 | - |
|
INBX Inhibrx Biosciences |
Biotechnology
Biologics, Therapeutics, Cancer |
1.22B | 41 | 0.21 | 34 | 99 | - |
|
AVBP ArriVent BioPharma |
Biotechnology
Firmonertinib, ARR-217, ARR-002 |
1.18B | 42 | 0.16 | 64 | 86 | - |
|
SVRA Savara |
Biotechnology
Rare Diseases, Respiratory |
1.16B | 42 | -0.63 | 66 | 90 | - |
|
ORIC Oric Pharmaceuticals |
Biotechnology
Cancer Therapies, Drug |
1.15B | 41 | -0.80 | 81 | 51 | - |
|
ALVO Alvotech |
Biotechnology
Biologics, Therapeutics |
1.13B | 19 | -1.00 | 36 | 1 | - |
|
ABCL Abcellera Biologics |
Biotechnology
Antibody Drugs, Drug Discovery |
1.11B | 41 | -0.16 | 77 | 30 | - |
|
IVA Inventiva S.A |
Biotechnology
Lanifibranor, Odiparcil, TGF-ß |
1.11B | 37 | -0.28 | 36 | 76 | - |
|
GERN Geron |
Biotechnology
Cancer Drugs, Therapeutics |
1.07B | 32 | -0.63 | 31 | 80 | - |
|
URGN UroGen Pharma |
Biotechnology
Cancer Drugs, Hydrogel Technology |
1.05B | 37 | -0.92 | 30 | 84 | - |
|
GHRS GH Research |
Biotechnology
Depression Treatments, Drug |
1.01B | 38 | -0.03 | 61 | 77 | - |
|
KALV Kalvista |
Biotechnology
Drug Therapies, Small Molecules |
993M | 45 | 0.07 | 26 | 86 | - |
|
MEDCL Medincell |
Biotechnology
Injectables, Pharmaceuticals |
984M | 47 | -0.22 | 35 | 56 | - |
|
QURE Uniqure |
Biotechnology
Gene Therapies, Rare Disease |
962M | 29 | -0.87 | 29 | 22 | - |
|
CTMX CytomX Therapeutics |
Biotechnology
Oncology Drugs, Biologics |
949M | 38 | 0.63 | 34 | 98 | - |
|
ANNX Annexon |
Biotechnology
Biologics, Small Molecules |
939M | 50 | 0.15 | 74 | 97 | - |
|
CMPX Compass Therapeutics |
Biotechnology
Tovecimig, CTX-471, CTX-8371 |
931M | 42 | 0.88 | 61 | 96 | - |
|
EVMN Evommune |
Biotechnology
Anti-Inflammatory Drugs |
919M | 35 | -0.20 | 81 | 85 | - |
|
SANA Sana Biotechnology |
Biotechnology
Cell Therapy, Diabetes Treatment |
918M | 35 | -0.45 | 66 | 38 | - |
|
XNCR Xencor |
Biotechnology
Antibodies, Biologics |
917M | 31 | -0.55 | 36 | 50 | - |
|
JANX Janux Therapeutics |
Biotechnology
Cancer Drugs, Immunotherapies |
908M | 15 | -0.40 | 26 | 8 | - |
|
OPK Opko Health |
Biotechnology
Diagnostics, Pharmaceuticals |
891M | 19 | 0.74 | 30 | 16 | - |
|
DRUG Bright Minds |
Biotechnology
Drug Development, Serotonin |
872M | 45 | 0.48 | 81 | 96 | - |
|
CGEM Cullinan Oncology |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
869M | 40 | -0.22 | 66 | 92 | - |
|
SLS Sellas Life Sciences |
Biotechnology
Cancer drugs, Immunotherapy, Small |
855M | 45 | -0.25 | 74 | 97 | - |
|
MNKD MannKind |
Biotechnology
Inhaled Insulin, Wearable Insulin |
846M | 34 | -0.28 | 26 | 2 | - |
|
BTX BlackRock |
Biotechnology
Technology, Private Equity |
844M | 25 | -0.12 | 56 | 63 | 12.7% |
|
SLDB Solid Biosciences |
Biotechnology
Gene Therapy, Dystrophy |
826M | 47 | 0.14 | 73 | 95 | - |
|
CDNA CareDx |
Biotechnology
Transplant Testing, Gene |
825M | 40 | 0.68 | 32 | 71 | - |
|
ABUS Arbutus Biopharma |
Biotechnology
Hepatitis B, RNAi, Immune Response |
811M | 27 | 0.05 | 24 | 76 | - |
|
PURR Hyperliquid |
Biotechnology
Biologic Medicines, Single Action |
807M | 44 | 0.71 | 92 | 93 | - |
|
SPRY ARS Pharmaceuticals |
Biotechnology
Neffy, Nasal, Epinephrine |
799M | 16 | -0.35 | 36 | 4 | - |
|
MGTX MeiraGTx Holdings |
Biotechnology
Gene Therapies, Ocular Treatments |
784M | 47 | -0.07 | 28 | 79 | - |
|
VOR Vor Biopharma |
Biotechnology
Cell Therapies, Gene Therapies |
780M | 41 | -0.88 | 79 | 9 | - |
|
KURA Kura Oncology |
Biotechnology
Cancer Drugs, Leukemia Treatment |
774M | 30 | -0.53 | 35 | 67 | - |
|
DSGN Design Therapeutics |
Biotechnology
Small Molecules, Genetic Diseases |
750M | 51 | -0.03 | 81 | 98 | - |
|
CSTL Castle Biosciences |
Biotechnology
Melanoma, Squamous-Cell, Uveal |
746M | 43 | 0.10 | 53 | 23 | - |
|
LXRX Lexicon |
Biotechnology
Drugs, Treatments, Research |
724M | 40 | -0.02 | 31 | 94 | - |
|
BBOT BridgeBio Oncology |
Biotechnology
Small Molecules, Cancer Drugs |
716M | 22 | -0.56 | 67 | 13 | - |
|
DRTS Alpha Tau Medical |
Biotechnology
Cancer Therapy, Radiation Therapy |
672M | 46 | 0.16 | 81 | 96 | - |
|
IRWD Ironwood |
Biotechnology
GI Therapies, Rare Disease, Pain |
659M | 64 | -0.03 | 31 | 99 | - |
|
PRME Prime Medicine |
Biotechnology
Gene Editing, Genetic Therapies |
619M | 43 | -0.74 | 71 | 75 | - |
|
OCGN Ocugen |
Biotechnology
Gene Therapy, Vaccines, Cell |
590M | 46 | -0.51 | 81 | 92 | - |
|
CLYM Climb Bio |
Biotechnology
Antibodies, Therapies, Diseases |
588M | 46 | 0.34 | 66 | 99 | - |
|
MDXG MiMedx |
Biotechnology
Placental Allografts, Amniotic |
575M | 49 | -2.14 | 85 | 2 | - |
|
UPB Upstream Bio |
Biotechnology
Asthma, Rhinosinusitis, COPD |
571M | 23 | -0.58 | 36 | 3 | - |
|
KYTX Kyverna |
Biotechnology
Cell Therapy, Autoimmune Disease |
569M | 50 | 0.11 | 78 | 97 | - |
|
TECX Tectonic |
Biotechnology
Biologics, Proteins, Antibodies |
563M | 46 | -0.41 | 81 | 90 | - |
|
ESPR Esperion |
Biotechnology
Cholesterol Medication |
560M | 31 | -1.21 | 25 | 70 | - |
|
ZVRA Zevra Therapeutics |
Biotechnology
KP1077, Celiprolol, AZSTARYS |
556M | 50 | 0.02 | 28 | 52 | - |
|
PRTA Prothena |
Biotechnology
Antibody, Vaccine |
555M | 32 | -0.20 | 66 | 71 | - |
|
VLA Valneva SE |
Biotechnology
Vaccines, Infectious diseases |
542M | 16 | -1.35 | 40 | 5 | - |
|
RIGL Rigel |
Biotechnology
Cancer Drugs, Blood Disorders |
540M | 56 | -0.20 | 34 | 76 | - |
|
ZURA Zura Bio Ordinary |
Biotechnology
Antibodies, Biologics, Therapeutics |
536M | 45 | -0.12 | 81 | 98 | - |
|
TRDA Entrada Therapeutics |
Biotechnology
Drug Delivery, RNA Therapeutics |
532M | 50 | -0.24 | 73 | 93 | - |
|
LYEL Lyell Immunopharma |
Biotechnology
Cell Therapy, Cancer Treatment |
522M | 44 | -0.68 | 81 | 93 | - |
Technical
Structure
Fundamental
Topics in GIC Sub-Industry »Biotechnology« (200+)
- Antibodies
- Clinical Trials
- Cancer Drugs
- Biologics
- Drug Development
- Therapeutics
- Therapies
- Cancer Therapies
- Treatments
- Gene Therapy
- Vaccines
- Small Molecules
- Medicines
- Drug Candidates
- Cell Therapy
- Cancer Treatments
- Oncology
- Rare Diseases
- Cancer
- Oncology Drugs
- Cell Therapies
- Drug Discovery
- Immunotherapy
- Rare Disease Therapies
- Inflammation
- Gene Therapies
- Pharmaceuticals
- Autoimmune
- Blood Disorders
- Diagnostics